Carine Dufau
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical study.
Journal: International journal of cancer
Published: September 19, 2024
Ceramide metabolism alterations contribute to Tumor Necrosis Factor-induced melanoma dedifferentiation and predict resistance to immune checkpoint inhibitors in advanced melanoma patients.
Journal: Frontiers in immunology
Published: April 22, 2024
A fluorogenic substrate for the detection of lipid amidases in intact cells.
Journal: Journal of lipid research
Published: November 16, 2023
Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives.
Journal: Cancers
Published: September 15, 2020
Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 02, 2020
New Insights into the Role of Sphingolipid Metabolism in Melanoma.
Journal: Cells
Published: July 17, 2020
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.
Journal: Cancer immunology research
Published: April 25, 2020
Anti-TNF, a magic bullet in cancer immunotherapy?
Journal: Journal for immunotherapy of cancer
Published: August 30, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026